These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 7450923)

  • 1. Relationship between the pharmacokinetics of a short-acting antiarrhythmic drug and its effects: studies with Falirytmin.
    Weiss M; Sziegoleit W; Machill K; Hafemeister G; Förster W
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):237-41. PubMed ID: 7450923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophysiological analysis of atrioventricular and intraventricular conduction in bi- and tri-fascicular blocks].
    Ducceschi V; Sarubbi B; Mayer MS; De Divitiis M; Briglia N; Scialdone A; Santangelo L; Iacono A
    Minerva Cardioangiol; 1997 Mar; 45(3):87-93. PubMed ID: 9213825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
    Terhaag B; Förster W
    Pharmazie; 1976; 31(9):635-9. PubMed ID: 1019213
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacokinetics of the new Soviet anti-arrhythmia preparation etacizin].
    Gneushev ET; Ponomarenko EL; Kurapov AP; Kukes VG
    Farmakol Toksikol; 1984; 47(2):52-4. PubMed ID: 6714405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic and electrophysiologic effects of the new calcium antagonist Ro 11-1781 (author's transl)].
    Bödeker K; Bischoff KO; Menken U; Hager W
    Z Kardiol; 1980 Nov; 69(11):790-6. PubMed ID: 7467662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative determination of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethylenediamine dihydrochloride (Falirytmin) in blood].
    Pönicke K; Hauer I; Sziegoleit W; Förster W
    Pharmazie; 1976; 31(9):613-4. PubMed ID: 1019208
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
    Atarashi H; Kuruma A; Yashima M; Saitoh H; Ino T; Endoh Y; Hayakawa H
    Clin Pharmacol Ther; 2000 Aug; 68(2):143-50. PubMed ID: 10976545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic and pharmacodynamic analysis of a class IC antiarrhythmic, pilsicainide, in patients with cardiac arrhythmias.
    Ogawa R; Kishi R; Mihara K; Takahashi H; Takagi A; Matsumoto N; Masuhara K; Nakazawa K; Miyake F; Kobayashi S; Echizen H
    J Clin Pharmacol; 2006 Jan; 46(1):59-68. PubMed ID: 16397285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamics, cardiac conduction and pharmacokinetics of mibefradil (Ro 40-5967), a novel calcium antagonist.
    Petrie JR; Glen SK; MacMahon M; Crome R; Meredith PA; Elliott HL; Reid JL
    J Hypertens; 1995 Dec; 13(12 Pt 2):1842-6. PubMed ID: 8903664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships and electrophysiological effects of short-acting amiodarone homologs in guinea pig isolated heart.
    Morey TE; Seubert CN; Raatikainen MJ; Martynyuk AE; Druzgala P; Milner P; Gonzalez MD; Dennis DM
    J Pharmacol Exp Ther; 2001 Apr; 297(1):260-6. PubMed ID: 11259553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential action of mexiletine on central common pathway of reentrant ventricular tachycardia.
    Aizawa Y; Abe A; Ohira K; Furushima H; Chinushi M; Fujita S
    J Am Coll Cardiol; 1996 Dec; 28(7):1759-64. PubMed ID: 8962563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
    Królicki A
    Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of intravenous magnesium on atrioventricular node conduction in supraventricular tachycardia.
    Stiles MK; Sanders P; Disney P; Brooks A; John B; Lau DH; Shashidhar ; Wilson L; Mackenzie L; Young GD
    Am J Cardiol; 2007 Oct; 100(8):1249-53. PubMed ID: 17920366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular function.
    Tuininga YS; Crijns HJ; Oosterhuis B; Wiesfeld AC; van Wijk LM; Albronda F; de Bruin H; Jonkman JH; Kozma C; Lie KI
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):408-14. PubMed ID: 7515984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a new antiarrhythmic drug: Craviten (M-71) on the ATP level in heart muscle slices in vitro.
    Gumińska M; Kedryna T; Marchut E; Eckstein M
    Pol J Pharmacol Pharm; 1980; 32(6):877-82. PubMed ID: 7243683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
    Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
    Foster D; Upton R; Christrup L; Popper L
    Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of some ethylenediamine derivatives with antiarrhythmic properties. I. Absorption, distribution in tissues and excretion of 14-C labelled N, N'-bis-[3-(p-methoxyphenoxy)-2-hydroxypropyl]-ethylenediamine dimethanesulphonate (MK-142) in rats.
    Nowicka A; Prussak T; Szukalski B
    Pol J Pharmacol Pharm; 1975; 27(2):113-20. PubMed ID: 168561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.